Corrigendum to “Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis”. Molecular Immunology 124 (2020) 161–171 (Molecular Immunology (2020) 124 (161–171), (S0161589020303886), (10.1016/j.molimm.2020.06.010))

João A. Oliveira-da-Silva, Daniela P. Lage, Fernanda F. Ramos, Amanda S. Machado, Grasiele S.V. Tavares, Débora V.C. Mendonça, Isabela A.G. Pereira, Vívian T. Martins, Lívia M. Carvalho, Fernanda Ludolf, Thaís T.O. Santos, Thiago A.R. Reis, Camila S. Freitas, Raquel S. Bandeira, Alessandra M. Silva, Lourena E. Costa, Jamil S. Oliveira, Mariana C. Duarte, Bruno M. Roatt, Antônio L. TeixeiraEduardo A.F. Coelho

Producción científica: Comment/debaterevisión exhaustiva

1 Cita (Scopus)

Huella

Profundice en los temas de investigación de 'Corrigendum to “Leishmania infantum pyridoxal kinase evaluated in a recombinant protein and DNA vaccine to protects against visceral leishmaniasis”. Molecular Immunology 124 (2020) 161–171 (Molecular Immunology (2020) 124 (161–171), (S0161589020303886), (10.1016/j.molimm.2020.06.010))'. En conjunto forman una huella única.

Medicine and Dentistry